China Regulatory Compliance for Life Sciences
Robert J Russell
90 Min
Product Id: 702037
China’s Life Sciences Compliance webinar will discuss the regulatory structure and requirements for compliance against China’s NMPA regulations for Pharmaceuticals, Medical Devices, Biologics and Combination Products.
What You Should Know About Export Requirements for FDA Regulated Products from US to Foreign Countries
Rossano V Gerald
60 Min
Product Id: 705186
When exporting outside the U.S., exporters must consider the Food and Drug Administration (FDA) provisions as it helps them understand what documents and procedures are needed in coordination with the transaction process. This training program will provide an in-depth explanation of FDA-regulated products that are exported from the United States to foreign countries. Also, it will address what export documentation must be used in the transportation of FDA-regulated products.
Phase I First-in-Man Studies: What is Special About How and Where These Trials are Conducted?
Charles H Pierce
90 Min
Product Id: 704842
This webinar will discuss the expectations of Phase 1 'First-in-Man' clinical studies, contrast the testing of pharmacokinetics and pharmacodynamics, differentiate safety testing in Phase 1 and 3 and describe the process of establishing the starting dose.
Compliance with the New ICH GCP revised 2 Guidelines
Laura Brown
60 Min
Product Id: 704989
This New ICH GCP E6 Revision 2 changes will cover those new requirements for running clinical trials, evaluate the changes and discuss how to implement these for sponsors, CROs and study sites. This session will enable you to meet the new international GCP standard to ensure the acceptance of clinical trial data by the regulatory authorities internationally including the European Union (EU), Japan, the United States, Canada and Switzerland.
Russia: Compliance Processes and Regulations
Robert J Russell
90 Min
Product Id: 703870
This training course will provide a detailed overview of the regulatory requirements, local challenges and important cultural aspects of working with the lifecycle of life science products (pharmaceuticals, medical devices, biologics and combination products) as an importer or producer in Russia. It will offer a deeper understanding of cultural norms, and will discuss best practices for establishing relationships and protecting your intellectual property to be integrated into your company’s training and corporate business strategies.
The New EU Clinical Trial Regulation
Robert J Russell
90 Min
Product Id: 703758
This course will present attendees with a clear understanding of the new processes and requirements for EU sponsors of clinical trials as the new regulation is published, rolled-out and implemented by the Member States, the European Medicines Agency and the European Commission.
How to Build Effective Metrics for Vendor Oversight
Beat Widler
60 Min
Product Id: 704766
This training program will explain what the critical areas and elements of vendor oversight are and how you can set such a system up for yourself at your company.
FDA vs. EU Inspections - Getting Prepared and What are Differences
Marie Dorat
75 Min
Product Id: 703516
This webinar will help attendees understand the FDA and EU inspection process and how to prepare for both of them. Attendees will learn the best practices to respond to Form 483 citations, Warning Letters and EU inspection findings.
South East Asia Regulatory Compliance for Life Science Products - Hong Kong, Taiwan, Thailand, Singapore, Malaysia and Vietnam
Robert J Russell
90 Min
Product Id: 702546
This training on South East Asia regulatory compliance for life science products will discuss the regulatory structure and requirements for compliance with in-country regulations for pharmaceuticals, medical devices, biologics and combination products. This webinar will focus on a high-level composite of requirements in Taiwan, Hong Kong, Singapore, Malaysia, Vietnam & Thailand.
The New European Union Clinical Trials Regulation: An Analysis of the Key Changes and their Implications for Future Clinical Trials
Ciara Farrell,Elisabethann Wright
60 Min
Product Id: 703445
This webinar will review the changes introduced by the new European Union ("EU") Clinical Trials Regulation and the implications for future clinical trials.
Walking the Minefield of Clinical Trial Budgets and Contracts; A Primer for Research Managers
Robert Romanchuk
90 Min
Product Id: 702373
This webinar will provide a basic understanding of regulations and statutes that people involved in the clinical research contract negotiation process must be aware of. You will learn how to negotiate for and create federally complaint agreements and thus avoid the risk associated with violations.
2-in-1 Virtual Seminar: FDA's Strategic Priorities and Supplier Control Requirements
John E Lincoln
3.5 hrs
Product Id: 703052
This virtual seminar will start by evaluating important areas for regulated companies to focus in 2013-2014, based on the U.S. FDA’s recent "Strategic Priorities" initiative. The second-half of the session will discuss how FDA's global initiatives affect supplier chain management and vendor audits and how you can prepare to address them.
Global Medical Device Laws and Regulations: US, EU, and Canada
David Lim
90 Min
Product Id: 702842
This training on global medical device regulations will discuss the regulatory framework for medical devices in US, EU and Canada. It will outline systematic methods to identify and meet regulatory requirements and streamline the regulatory process in these countries.
Asian Medical Device Laws and Regulations: China, Hong Kong, Japan and Korea
David Lim
90 Min
Product Id: 702841
This training on Asian medical device regulations will discuss the regulatory framework for medical devices in China, Hong Kong, Japan and Korea. It will outline systematic methods to identify and meet regulatory requirements and streamline the regulatory process in these Asian countries.
CRO or ARO: How to Hire and Manage One
Ethel Kagan, R.N., B.A.
60 Min
Product Id: 702232
This training on hiring and managing CROs or AROs will show how you can ensure that you choose the right CRO/ARO based on the phase of the trial, the therapeutic area and the countries that the trials will be conducted.